Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 20, 2021
- Accepted in final form August 27, 2021
- First Published September 20, 2021.
Article Versions
- Previous version (September 20, 2021 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Adam de Havenon, MD,
- Alicia Castonguay, PhD,
- Raul Nogueira, MD,
- Thanh N. Nguyen, MD,
- Joey English, MD,
- Sudhakar Reddy Satti, MD,
- Erol Veznedaroglu, MD,
- Jeffrey L. Saver, MD, MBA,
- J. Mocco, MD,
- Pooja Khatri, MD,
- Eva Mistry, MBBS and
- Osama O. Zaidat, MD
- Adam de Havenon, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) AMAG Pharmaceuticals, 2) Regeneron Pharmaceuticals
1) NIH/NINDS, K23NS105924, Primary Investigator, 2019-2024 Stock/Stock Options, Medical Equipment & Materials: 1) Certus Critical Care
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Alicia Castonguay, PhD,
NONE
NONE
NONE
Frontiers of Neurology, Associate Editor, 2021
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Raul Nogueira, MD,
RGN reports consulting fees for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, Synchron, and stock options for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze.
NONE
NONE
Interventional Neurology journal - Editor-In-Chief - no compensation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
RGN is one of the Principal Investigators of the ÂEndovascular Therapy for Low NIHSS Ischemic Strokes (ENDOLOW)Â trial. Funding for this project is provided by Cerenovus to Emory University. Dr. Nogueira serves as a consultant to Cerenovus and receives compensation for these services. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policies. Stock/Stock Options, Medical Equipment & Materials: RGN is an investor in Viz-AI, Perfuze, Cerebrotech, Reist LLC, Truvic, and Viseon.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
RGN has served as expert testimony to legal proceedings for the United States AttorneyÂs Office, Muro & Lampe, Inc., Sandberg Phoenix, Lashly & Baer, Rissman, Barrett & Mangan, P.A and Schuering Zimmerman & Doyle, LLP Law Firms.
- Thanh N. Nguyen, MD,
Vesalio, non-profit CREST 2, non-profit
NONE
NONE
Frontiers in Neurology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
1) Medtronic
NONE
NONE
1) Society of Vascular and Interventional Neurology
NONE
NONE
NONE
NONE
NONE
NONE
- Joey English, MD,
NONE
NONE
NONE
NONE
1) Route 92 Medical, neurovascular catheters and catheter delivery devices
NONE
NONE
1) Stryker Neurovascular Stock/Stock Options, Medical Equipment & Materials: 1) Co-founder and Equity Owner, Route 92 Medical
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sudhakar Reddy Satti, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Consult for: (all commercial) Balt Stryker Neurovascular Cerenovus Microvention Terumo Cordis Penumbra Q'Apel
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Erol Veznedaroglu, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Penumbra - consultant Longevity - consultant Trice - consultant
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jeffrey L. Saver, MD, MBA,
Dr. Saver has received contracted hourly payments and travel reimbursement for service on Clinical Trial Steering Committees and Data and Safety Monitoring Boards advising on rigorous clinical trial design and conduct to Medtronic, Stryker, Cerenovus/Johnson+Johnson, BrainsGate, Boehringer Ingelheim (prevention only), NONO Inc, Novo NorDisk, Abbott, and the National Institutes of Health. Dr. Saver has received contracted stock options for services as a scientific consultant advising on rigorous trial design and conduct to Rapid Medical.
NONE
NONE
Dr Saver served: at JAMA as Associate Editor for Neurology/Neurosurgery throughout the past 2 years; at Stroke as Consulting Editor within the past 2 years, at Journal of Neuroimaging as an Editorial Board Member throughout the past 2 years; at Journal of Stroke and Cerebrovascular Diseases as an Editorial Board Member throughout the past 2 years; and at the journal Circulation within the past 2 years.
NONE
NONE
NONE
NONE
NONE
NONE
Acute stroke care, 35% of effort. Stock/Stock Options, Medical Equipment & Materials: Dr. Saver received stock options in for services as a scientific consultant regarding trial design and conduct to Rapid Medical.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- J. Mocco, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Imperative Care (2) Cerebrotech (3) Viseon (4) Endostream (5) Vastrax (6) RIST (7) Synchron (8) Viz.ai (9) Perflow (10) CVAid
NONE
NONE
NONE
(1) Stryker Neurovascular (2) Microvention (3) Penumbra Stock/Stock Options, Medical Equipment & Materials: (1)Imperative Care (2)Cerebrotech (3)Viseon (4)Endostream (5) Cardinal Consulting (6)RIST (7)Synchron (8)Viz.ai (9)BlinkTBI (10)Serenity (11)Truvic
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pooja Khatri, MD,
(1) Diamedica (SAB) (2) Lumosa (company medical representative on DSMB) (3) Basking Biosciences (SAB)
NONE
NONE
Stroke, Associate Editor, 2020-current
NONE
UpToDate, Inc -- ongoing update to Stroke after Cardiac Catheterization article
NONE
Lumosa
NONE
NONE
NONE
1) Cerenovus (IIS grant) 2) Bayer (National PI effort)
1. NIH/NINDS U24, StrokeNET RCC PI 2. NIH/NINDS U01, StrokeNET NCC MPI 3. NIH/NINDS R01, APRISE MPI 4. NIH/NINDS RF1, APRISE-Dementia-MPI 5. NIH/NINDS, OTA, ACTIV-4A abd ACTIV-4C 6. NIH/NINDS, U01, SATURN 6. NIH/NINDS, U01, ASPIRE 6. NIH/NINDS, U01, FASTEST
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Eva Mistry, MBBS and
NONE
NONE
NONE
Associate Editor since July 2021 for Stroke: Vascular and Interventional Neurology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NIH/NINDS K23NS113858, Role: PI, 2019-2024
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Osama O. Zaidat, MD
NONE
NONE
Consultant and Speaker for Stryker Cerenovous Penumbra Medtronic
Frontiers in Neurology/Endovascular & Interventional editor Editorial Board Journal of Stroke & Cerebrovascular Diseases
Ischemic stroke device and aneurysm device patents
NONE
NONE
Consultant and Speaker for Stryker Cerenovous Penumbra Medtronic
NONE
NONE
NONE
Research support for investigator initiated research: Stryker Cerenovous Penumbra Medtronic
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (A.d.H.), University of Utah, Salt Lake City; Department of Neurology (A.C.), University of Toledo, OH; Department of Neurology, Neurosurgery, and Radiology (R.N.), Emory University, Atlanta, GA; Department of Neurology, Neurosurgery, and Radiology (T.N.N.), Boston Medical Center, MA; California Pacific Medical Center (J.E.), San Francisco; Department of Neurointerventional Surgery (S.R.S.), Christiana Care Health System, Newark, DE; Department of Neurosurgery (E.V.), Drexel Neurosciences Institute, Philadelphia, PA; Department of Neurology (J.L.S.), University of California, Los Angeles; Department of Neurosurgery (J.M.), Mt. Sinai, New York, NY; Department of Neurology (P.K.), University of Cincinnati, OH; Department of Neurology (E.M.), Vanderbilt Medical Center, Nashville, TN; and Department of Neurology (O.O.Z.), Mercy Health–St. Vincent Medical Center, Toledo, OH.
- Correspondence
Dr. de Havenon adam.dehavenon{at}hsc.utah.edu
Article usage
Cited By...
Letters: Rapid online correspondence
- Reader Response: Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke
- Askiel Bruno, Neurologist, Medical College of Georgia at Augusta University
- Jeffrey Switzer, Neurologist, Medical College of Georgia at Augusta University
- Fenwick Nichols, Neurologist, Medical College of Georgia at Augusta University
Submitted March 16, 2022 - Author Response: Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke
- Adam de Havenon, Physician, Yale University
Submitted February 17, 2022 - Reader Response: Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke
- Qian Feng, Neurologist, Department of Neurology, The Affiliated Suzhou Hospital, Nanjing Medical University, Suzhou City, China
- Hua Zhou, Neurologist, Department of Neurology, The Affiliated Suzhou Hospital, Nanjing Medical University, Suzhou City, China
- Zhong Zhao, Neurologist, Department of Neurology, The Affiliated Suzhou Hospital, Nanjing Medical University, Suzhou City, China
Submitted December 16, 2021 - Reader Response: Prestroke Disability and Outcome After Thrombectomy for Emergent Anterior Circulation Large Vessel Occlusion Stroke
- James E. Siegler, Neurologist, Cooper Neurological Institute
- Nicholas Vigilante, Medical Student, Cooper Medical School of Rowan University
Submitted September 28, 2021
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker
► Watch
Related Articles
- No related articles found.